|
2023
|
P/S
|
Pharmaceutical preparations and substances containing small molecule active pharmaceutical ingred... |
|
2022
|
P/S
|
Diagnostic preparations for clinical or medical laboratory use; Diagnostic reagents for clinical ... |
|
|
P/S
|
Chemical substances for use in the manufacture of pharmaceutical preparations for the treatment o... |
|
2021
|
P/S
|
Pharmaceutical preparations and substances for the treatment of infectious diseases, for the trea... |
|
2018
|
Invention
|
Use of phospho-akt as a biomarker of drug response. 5 together represent methylenedioxy; and phar... |
|
|
Invention
|
Use of glu-tubulin as a biomarker of drug response to furazanobenzimidazoles. Use of glu-tubulin ... |
|
2017
|
Invention
|
Process for the manufacture of isavuconazole or ravuconazole. The invention relates to a process ... |
|
|
P/S
|
Pharmaceutical preparations for the prevention and/or treatment of: dermatological conditions, na... |
|
|
Invention
|
Selected macrolides with pde4-inhibiting activity. The application relates to the macrolide compo... |
|
2016
|
Invention
|
Use of acetylated tubulin as a biomarker of drug response to furazanobenzimidazoles. Use of acety... |
|
|
P/S
|
Pharmaceutical products and preparations, namely, for the treatment and prevention of infections ... |
|
|
Invention
|
Use of bubr1 as a biomarker of drug response to furazanobenzimidazoles. Use of BUBR1 as a biomark... |
|
|
Invention
|
Useful combinations of monobactam antibiotics with beta-lactamase inhibitors.
A pharmaceutical c... |
|
2015
|
Invention
|
Dosage principle for anti-cancer furazanylbenzimidazoles. Disclosed is a novel principle for dosi... |
|
2014
|
Invention
|
Bicyclic antibiotics. The antibacterial compound of formula I
X5 represents C—H or C—(C1-C6alkyl... |
|
|
Invention
|
Tricyclic antibiotics. The present invention relates to antibacterial compounds of formula I:
w... |
|
|
Invention
|
Useful combinations of monobactam antibiotics with beta-lactamase inhibitors. A pharmaceutical co... |
|
|
Invention
|
Crystalline (6r,7r)-7-{2-(5-amino-[1,2,4] thiadiazol-3-yl)-2-[(z)-trityloxyimino]-acetylamino}-3-... |
|
|
Invention
|
Macrolides and their use. The invention relates to macrolide compounds of formula (I),
the use o... |
|
|
P/S
|
Chemical preparations for use in the pharmaceutical industry as well as chemical preparations for... |
|
2013
|
Invention
|
Combination therapy for the treatment of cancer and immunosuppression. The invention relates to n... |
|
|
Invention
|
Combination medicaments for treating bacterial infections. Use of a monobactam antibiotic of form... |
|
|
Invention
|
Bridged monobactam intermediates. C1-C6Alkyloxy- or benzyloxy-carbonyl esters of -{3-[(E)-(1-phen... |
|
|
P/S
|
Pharmaceutical preparations and substances. |
|
2012
|
Invention
|
Tricyclic antibiotics. Compounds of formula (I), wherein A1 represents -0-, -S- or -CH2-; A2 repr... |
|
|
Invention
|
Use of phospho-akt as a biomarker of drug response. Use of phospho-Akt as a biomarker for predict... |
|
|
Invention
|
Use of stathmin as a biomarker of drug response to furazanobenzimidazoles. Use of stathmin as a b... |
|
2011
|
P/S
|
Pharmaceutical preparations and substances, namely
antifungals. |
|
2010
|
Invention
|
Tricyclic antibiotics. Compound of formula (I): wherein A1 represents -O-, -S- or -N-R3; A2 repre... |
|
|
Invention
|
Process for the manufacture of epoxy triazole derivatives. Disclosed is a process for the manufac... |
|
|
Invention
|
Macrolides and their use. The invention relates to macrolide compounds of formula (I), the use of... |
|
|
Invention
|
New macrolides and their use. The invention relates to macrolide compounds of formula (I), the us... |
|
|
Invention
|
Furazanobenzimidazoles as prodrugs to treat neoplastic or autoimmune diseases. A compound of form... |
|
|
Invention
|
Novel bicyclic antibiotics. Compounds of formula (I) wherein X1, X3; X4 and X6, each independentl... |
|
2009
|
Invention
|
Macrolides and their use. The invention relates to antibiotic macrolides of formula (I),
which h... |
|
|
Invention
|
Macrolides and uses of macrolides. Macrolides of Formula (I) or (I-A): and wherein the residues R... |
|
2008
|
Invention
|
Process for the preparation of 2-(primary/secondary amino)hydrocarbyl)-carbamoyl-7-oxo-2,6-diaza-... |
|
|
Invention
|
Process for the manufacture of bridged monobactam intermediates. 6alkyl group or an unsubstituted... |
|
|
Invention
|
Antifungal composition. 3 are independently of one another hydrogen, F or Cl; or a pharmaceutical... |
|
|
P/S
|
Chemical preparations (for use in the pharmaceutical
industry as well as chemical preparations f... |
|
2007
|
P/S
|
Chemicals used in industry; chemicals used in science
(except for medical or veterinary use). Ph... |
|
2006
|
P/S
|
Chemical substances for use in the pharmaceutical industry and in research and development of pha... |
|
|
P/S
|
Pharmaceutical products and substances. |
|
2005
|
Invention
|
Furazanobenzimidazoles. 6 have the meanings given in the specification, for use as medicaments, t... |
|
2001
|
P/S
|
Pharmaceutical preparations. |
